Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  Abacus Health Products, Inc.    ABCS   CA00258K1049

ABACUS HEALTH PRODUCTS, INC.

(ABCS)
  Report
SummaryQuotesNewsRatingsCompanyFinancials 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Abacus Health Products : Announces Release Date for 2020 First Quarter Financial Results

share with twitter share with LinkedIn share with facebook
05/25/2020 | 12:33pm EDT

WOONSOCKET - Abacus Health Products, Inc. (CSE: ABCS, OTCQB: ABAHF) ('Abacus' or the 'Company') announces that it will release its 2020 first quarter financial results on Thursday, May 28, 2020, prior to the market open.

The Company will not be hosting a conference call to discuss the results. The Company intends to hold the previously-announced special shareholders meeting ('Meeting') on Thursday, June 4, 2020 at 10:00 a.m. (EDT) to consider and vote upon its proposed acquisition by Charlotte's Web Holdings, Inc.

About Abacus Health Products, Inc.

Abacus is principally engaged in the development and commercialization of over-thecounter (OTC) topical medications with active pharmaceutical ingredients and which contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD from the Cannabis sativa L plant. Abacus' products are aimed at the rapidly growing markets for topical pain relief and therapeutic skincare and are based on proprietary patent-pending technologies developed by Abacus. Abacus' formulations combine advanced science with organic and natural ingredients to provide safe relief. Abacus currently offers three lines of products: CBD CLINIC, marketed to the professional practitioner market, and CBDMEDIC and Harmony Hemp, marketed to the consumer market. Abacus' products are offered across the United States and are produced by contract manufacturers, including in an FDA registered and audited manufacturing facility.

Contact:

Bill Mitoulas

Tel: 1.416.479.9547

Email: bill@abacushp.com

(C) 2020 Electronic News Publishing, source ENP Newswire


share with twitter share with LinkedIn share with facebook
All news about ABACUS HEALTH PRODUCTS, INC.
06/11CSE BULLETIN : Delist - Abacus Health Products Inc. (ABCS and ABCS.WT)
NE
06/11CHARLOTTE WEB : Acquires Abacus Health Products
AQ
06/08ABACUS HEALTH PRODUCTS : Receives Court Approval for Arrangement with Charlotte'..
BU
06/04ABACUS HEALTH PRODUCTS : rsquo; Shareholders Approve Arrangement with Charlotte'..
BU
05/28ABACUS HEALTH PRODUCTS : Reports First Quarter 2020 Financial Results
BU
05/25ABACUS HEALTH PRODUCTS : Announces Release Date for 2020 First Quarter Financial..
AQ
05/25ABACUS HEALTH PRODUCTS : Announces ISS and Glass Lewis Recommendations For its P..
BU
05/22ABACUS HEALTH PRODUCTS : Announces Release Date for 2020 First Quarter Financial..
BU
05/08ABACUS HEALTH PRODUCTS : Announces Special Meeting of Shareholders and Filing of..
BU
04/29ABACUS HEALTH PRODUCTS : Reports Fourth Quarter and Year-End 2019 Financial Resu..
BU
More news
Financials (USD)
Sales 2019 15,5 M - -
Net income 2019 -16,6 M - -
Net cash 2019 21,9 M - -
P/E ratio 2019 -7,01x
Yield 2019 -
Capitalization 112 M 114 M -
EV / Sales 2018 -
EV / Sales 2019 4,98x
Nbr of Employees 57
Free-Float -
Chart ABACUS HEALTH PRODUCTS, INC.
Duration : Period :
Abacus Health Products, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers
NameTitle
Perry Antelman Chairman & Chief Executive Officer
Charlie Hughes Vice President-Operations
Henry R Hague Chief Financial Officer
Bharat Madhavan Chief Technology Officer
Phillip Charles Henderson Director